Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2020 - 2025)
Neuroone Medical Technologies' Asset Utilization Ratio history spans 10 years, with the latest figure at 0.9 for Q4 2025.
- For Q4 2025, Asset Utilization Ratio fell 7.11% year-over-year to 0.9; the TTM value through Dec 2025 reached 0.9, down 7.11%, while the annual FY2025 figure was 1.13, 119.63% up from the prior year.
- Asset Utilization Ratio reached 0.9 in Q4 2025 per NMTC's latest filing, up from 0.84 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.05 in Q1 2025 to a low of 0.01 in Q1 2021.
- Average Asset Utilization Ratio over 5 years is 0.39, with a median of 0.24 recorded in 2023.
- Peak YoY movement for Asset Utilization Ratio: crashed 36.02% in 2021, then skyrocketed 1908.19% in 2023.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then soared by 100.53% to 0.02 in 2022, then soared by 1704.59% to 0.4 in 2023, then soared by 139.58% to 0.97 in 2024, then fell by 7.11% to 0.9 in 2025.
- Per Business Quant, the three most recent readings for NMTC's Asset Utilization Ratio are 0.9 (Q4 2025), 0.84 (Q3 2025), and 0.87 (Q2 2025).